ABCG2 and neoplasm: Efflux transporters such as P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) can impede the penetration of standard chemotherapeutic agents such as temozolomide (TMZ) and reduce their concentration at the tumor site, limiting their efficacy [12].